BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND RUNX1T1, ENSG00000079102, 862 AND Diagnosis
71 results:

  • 1. Usefulness of KIT mutant transcript levels for monitoring measurable residual disease in t (8;21) acute myeloid leukemia.
    Sun Y; Wang X; Chen WM; Hao Y; Li LD; Li JY; Sun K; Shi ZY; Jiang H; Jiang Q; Huang XJ; Qin YZ
    Hematol Oncol; 2024 Mar; 42(2):e3264. PubMed ID: 38461410
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. CNS erythroblastic sarcoma: a potential emerging pediatric tumor type characterized by NFIA::runx1t1/3 fusions.
    Tauziède-Espariat A; Lew-Derivry L; Abbou S; Métais A; Pierron G; Reynaud S; Masliah-Planchon J; Mariet C; Hasty L; Dangouloff-Ros V; Boddaert N; Csanyi M; Aline-Fardin A; Lamaison C; Chrétien F; Beccaria K; Puget S; Varlet P
    Acta Neuropathol Commun; 2024 Jan; 12(1):12. PubMed ID: 38243303
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Mixed-phenotype acute leukemia, T/megakaryoblastic: does it really exist?
    Mansoor N; Javed O; Rafiq N; Aali A; Meraj F
    J Hematop; 2023 Mar; 16(1):49-55. PubMed ID: 38175376
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Single-cell RNA-seq reveals novel immune-associated biomarkers for predicting prognosis in AML patients with RUNX1::runx1t1.
    Li XP; Dai Y; Zhang WN; Pan MM; Mao J; Zhao B; Jiang L; Gao Y
    Int Immunopharmacol; 2023 Dec; 125(Pt B):111178. PubMed ID: 37951201
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Automated Deep Learning-Based diagnosis and Molecular Characterization of Acute Myeloid leukemia Using Flow Cytometry.
    Lewis JE; Cooper LAD; Jaye DL; Pozdnyakova O
    Mod Pathol; 2024 Jan; 37(1):100373. PubMed ID: 37925056
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Systemic Mastocytosis with Associated Hematological Neoplasms. Diagnostic features and unique response pattern to tyrosine kinase inhibitors and allo-bone marrow transplantation therapy.
    Hernández Alconchel I; González de Villambrosía S; Insunza Gaminde A; Montes Moreno S
    Rev Esp Patol; 2023; 56(3):180-185. PubMed ID: 37419556
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. European cancer mortality predictions for the year 2023 with focus on lung cancer.
    Malvezzi M; Santucci C; Boffetta P; Collatuzzo G; Levi F; La Vecchia C; Negri E
    Ann Oncol; 2023 Apr; 34(4):410-419. PubMed ID: 36882139
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Validation of the prognostic significance of the 2022 European leukemiaNet risk stratification system in intensive chemotherapy treated aged 18 to 65 years patients with de novo acute myeloid leukemia.
    Lo MY; Tsai XC; Lin CC; Tien FM; Kuo YY; Lee WH; Peng YL; Liu MC; Tseng MH; Hsu CA; Chen JC; Lin LI; Sun HI; Chuang YK; Ko BS; Tang JL; Yao M; Chou WC; Hou HA; Tien HF
    Am J Hematol; 2023 May; 98(5):760-769. PubMed ID: 36861732
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Fusion Gene-Based Classification of Variant Cytogenetic Rearrangements in Acute Myeloid leukemia.
    Gudipati M; Butler M; Koka R; Baer MR; Ning Y
    Genes (Basel); 2023 Feb; 14(2):. PubMed ID: 36833323
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Immunohistochemical Staining to Identify Concomitant Systemic Mastocytosis in Acute Myeloid leukemia with
    Hwang SM; Kim BJ; Lee JS; Seong MW; Seo SH; Paik JH; Kim SA; Lee JY; Lee JO; Chang YH; Bang SM
    Ann Lab Med; 2022 Nov; 42(6):678-682. PubMed ID: 35765876
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Analysis of risk factors of relapse after allogeneic hematopoietic stem cell transplantation in patients with t (8;21) acute myeloid leukemia].
    Guo WW; Liu X; Pang AM; Zhai WH; Yang DL; Chen X; Ma QL; He Y; Zhang RL; Feng SZ; Han MZ; Jiang EL
    Zhonghua Xue Ye Xue Za Zhi; 2021 Dec; 42(12):998-1004. PubMed ID: 35045670
    [No Abstract]    [Full Text] [Related]  

  • 12. Droplet digital polymerase chain reaction assay for the detection of the minor clone of KIT D816V in paediatric acute myeloid leukaemia especially showing RUNX1-runx1t1 transcripts.
    Sasaki K; Tsujimoto S; Miyake M; Uchiyama Y; Ikeda J; Yoshitomi M; Shimosato Y; Tokumasu M; Matsuo H; Yoshida K; Ohki K; Kaburagi T; Yamato G; Hara Y; Takeuchi M; Kinoshita A; Tomizawa D; Taga T; Adachi S; Tawa A; Horibe K; Hayashi Y; Matsumoto N; Ito S; Shiba N
    Br J Haematol; 2021 Jul; 194(2):414-422. PubMed ID: 34120331
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Clinicopathological Evaluation of Acute leukemias in a Tertiary Care Hospital: A Cross-Sectional Study.
    Patel GN; Gudur R; Gudur A; Oswal RM; Kanethkar S
    Turk Patoloji Derg; 2021; 37(2):145-153. PubMed ID: 33973643
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. A novel case of intrachromosomal amplification and insertion of RUNX1 on derivative chromosome 2 in pediatric AML.
    Jain H; Shetty D; Roy Moulik N; Narula G; Subramanian PG; Banavali S
    Cancer Genet; 2021 Jun; 254-255():65-69. PubMed ID: 33647813
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Development and validation of a disease risk stratification system for patients with haematological malignancies: a retrospective cohort study of the European Society for Blood and Marrow Transplantation registry.
    Shouval R; Fein JA; Labopin M; Cho C; Bazarbachi A; Baron F; Bug G; Ciceri F; Corbacioglu S; Galimard JE; Giebel S; Gilleece MH; Giralt S; Jakubowski A; Montoto S; O'Reilly RJ; Papadopoulos EB; Peric Z; Ruggeri A; Sanz J; Sauter CS; Savani BN; Schmid C; Spyridonidis A; Tamari R; Versluis J; Yakoub-Agha I; Perales MA; Mohty M; Nagler A
    Lancet Haematol; 2021 Mar; 8(3):e205-e215. PubMed ID: 33636142
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. RNA sequencing as an alternative tool for detecting measurable residual disease in core-binding factor acute myeloid leukemia.
    Kim T; Moon JH; Ahn JS; Ahn SY; Jung SH; Yang DH; Lee JJ; Shin MG; Choi SH; Lee JY; Tyndel MS; Lee HY; Kim KH; Cai Y; Lee YJ; Sohn SK; Min YH; Cheong JW; Kim HJ; Zhang Z; Kim DDH
    Sci Rep; 2020 Nov; 10(1):20119. PubMed ID: 33208771
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Allogeneic hematopoietic stem cell transplantation can improve the prognosis of high-risk pediatric t(8;21) acute myeloid leukemia in first remission based on MRD-guided treatment.
    Hu GH; Cheng YF; Lu AD; Wang Y; Zuo YX; Yan CH; Wu J; Sun YQ; Suo P; Chen YH; Chen H; Jia YP; Liu KY; Han W; Xu LP; Zhang LP; Huang XJ
    BMC Cancer; 2020 Jun; 20(1):553. PubMed ID: 32539815
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. A new complex translocation (8;22;21)(q22;q12;q22) in RUNX1/runx1t1 acute myeloid leukaemia.
    Tay Za K; Shanmugam H; Chin EFM
    Malays J Pathol; 2019 Dec; 41(3):333-338. PubMed ID: 31901918
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [Related Factors Affecting Long-term Prognosis of AML Children with Positive RUNX1-runx1t1].
    Teng GY; Qu WJ; Zhang K
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Dec; 27(6):1767-1773. PubMed ID: 31839036
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [Characteristic and prognostic significance of leukemia stem cells associated antigens expressions in t (8;21) acute myeloid leukemia].
    Dao FT; Yang L; Wang YZ; Chang Y; Jiang Q; Jiang H; Liu YR; Huang XJ; Qin YZ
    Zhonghua Xue Ye Xue Za Zhi; 2019 Oct; 40(10):831-836. PubMed ID: 31775482
    [No Abstract]    [Full Text] [Related]  


    [Next]

    of 4.